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Background/aim: We aimed to evaluate the size/tortuosity of the optic nerve (ON) and the dilatation of the ON sheath (ONS) in
neurofibromatosis type 1 (NF-1) patients with 3T-MRI, and to assess the usefulness of 3D-SPACE in imaging the optic pathway, ON,
and ONS in NF-1 patients.
Materials and methods: Twenty consecutive NF-1 patients without optic pathway glioma (OPG) (Group 1), 16 consecutive NF-1
patients with OPG (Group 2), and 19 controls were included in this study. The thickness and tortuosity of the ON and the diameter of
the ONS were measured on STIR and 3D-SPACE images.
Results: The thickness of the ON was similar in all groups on STIR images (P>0.05). The mean ONS diameter was higher in Group 2
with this sequence (P=0.009). Controls had significantly lower grades of ON tortuosity than Groups 1 and 2 (P=0.001), and Group 1 had
significantly lower ON tortuosity compared to Group 2 (P=0.001). Severe tortuosity was only detected in Group 2.
Conclusion: ON tortuosity and ONS diameter were increased in NF-1 patients in the presence of OPG. High-resolution cranium
imaging with the 3D-SPACE technique using 3T-MRI seems to be helpful for detection of the optic pathway morphology and pathologies
in NF-1 patients.
Key words: Neurofibromatosis type 1, optic pathway glioma, 3D-SPACE, optic nerve thickness, optic nerve sheath diameter, optic nerve
tortuosity

1. Introduction
Neurofibromatosis type 1 (NF-1) is an autosomal dominant
neurocutaneous disorder characterized by multiple
neurofibromas, cutaneous pigmentation, and skeletal
dysplasia [1]. Individuals with NF-1 typically present in
childhood with café-au-lait spots, inguinal and axillary
freckling, and Lisch nodules on the iris [2]. Numerous
central nervous system (CNS) manifestations have been
identified in NF-1 including optic pathway gliomas
(OPGs), optic nerve tortuosity, cerebral astrocytomas,
hydrocephalus, and neurofibromatosis bright objects
(NBOs) on imaging [3].
OPGs are the most common CNS neoplasms in NF-1,
encountered in 15% of NF-1 patients [1,4]. They generally
involve the anterior visual pathway. Although 45% are

intraorbital, they can arise from anywhere else in the
visual pathway including the optic chiasm, optic tracts,
and optic radiations [1]. The last location is relatively rare
but exhibits more aggressive behavior [4–8].
Magnetic resonance imaging (MRI) is the method
of choice for detection and evaluation of OPGs and
other intracranial manifestations of NF-1 because of its
higher soft-tissue contrast resolution and radiation-free
multiplanar imaging capability [9]. Many institutions
perform MRI screening of the brain in all young patients
with NF-1 and chiasm with thin slices through the optic
nerves, and some authors argued that they only perform
MRI when a reliable eye exam cannot be obtained or
there are other clinical abnormalities [1,6–8]. As a result,
many patients with NF-1 undergo MRI during childhood.
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In certain cases, multiple MRIs including brain, orbital,
and/or phase-contrast cine are performed for accurate
demonstration of the CNS lesion [8]. Multiple imaging
examinations have their own disadvantages, such as
lower patient cooperation and comfort, higher specific
absorption rate (SAR) level, and increased imaging time/
cost [10]. New achievements in MRI technology allow the
entire cranium to be scanned three-dimensionally (3D)
in thin sections within 5 min by 3D sampling perfection
and application-optimized contrasts using the different
flip-angle evolutions (3D-SPACE) technique [11]. The
3D-SPACE technique has the capacity to determine all
CNS manifestations of NF-1 patients and give additional
information undetectable with routine MRI sequences in
clinical settings.
Optic nerve (ON) tortuosity and ON sheath (ONS)
dilatation are abnormalities of patients with NF-1 [8]. They
generally are identified incidentally. Their significance in
the prognosis of NF-1 patients is not known in current
clinical practice yet. The incidence of ON tortuosity in
patients with NF-1 was between 12% and 31% in previous
studies [8,12].
We evaluated the optic pathways of NF-1 patients with
and without OPG with a 3-Tesla (3T) MRI unit. In this
study we had two aims: first, to assess the relationship
between the presence of OPG and the thickness/tortuosity
of the ON and the diameter of the ONS, and second, to
investigate the significance of 3D-SPACE sequences in the
assessment of the optic pathway of NF-1 patients using
a 3T-MRI unit. To our knowledge, this is the first study
evaluating the optic pathway with 3D-SPACE sequences in
NF-1 patients using 3T-MRI.
2. Materials and methods
This prospective study was conducted in compliance with
institutional and government review board regulations,
informed consent regulations, and the Declaration of
Helsinki during a 3-year period. Written informed consent
was obtained from all patients and control subjects before
the clinical and radiological evaluations.
Twenty NF-1 patients without OPG (Group 1), 16
NF-1 patients with OPG (Group 2), and 19 healthy
subjects with normal neurological and ophthalmological
examinations (control group) were enrolled in this study.
Subjects with any history of neurological disease, allergy,
claustrophobia, ferromagnetic implants or pacemakers,
renal failure, meningitis, and pregnancy were excluded.
In five cases, screening failures occurred. These cases were
also excluded from the study. The presence or absence
of OPG was defined subjectively by an experienced
neuroradiologist (O.A.) according to the literature [1–8].
Presence of headache was also subjectively questioned and
recorded.

The diagnosis of NF-1 was made according to the National
Institutes of Health Consensus Development Conference
diagnostic criteria [1]. After the neuroophthalmological
examination, 3T-MRI acquisitions were obtained from
all subjects. A neuroradiologist (O.A.) evaluated the MRI
data during acquisition; if needed, intravenous contrast
medium (0.3 mL/kg Dotarem) was administered before
the 3D-SPACE and STIR sequences and postcontrast T1W
images were obtained. MRI protocol is given in Table 1.
MRI examinations were performed using a 3T unit (Trio
with Tim; Siemens Healthcare AG, Erlangen, Germany)
with a birdcage multichannel head coil.
Multiplanar and curved reformatted images were
obtained with Neuro 3D software (Siemens Healthcare AG,
Germany), except the STIR sequence, because routine STIR
is a 2D sequence. The thickness of the ON and the diameter
of the ONS were measured on short tau inversion recovery
(STIR) and 3D-SPACE images by another neuroradiologist
(M.B.). For each eye, two measurements were made from
the thickest part of the ON and ONS, which did not involve
the qualitatively (visually) detectable part of the OPG
(Figure 1). The mean value of these two measurements was
calculated and considered as the exact value of each eye.
The measurements were made subjectively by each rater
in a uniform manner between outer margins on axial and
coronal images. The rater (M.B.) was blinded to the patient
group during the evaluations. All measurements were made
for the intraconal thickest part of the ON for both eyes
separately. If the ON and/or ONS boundaries could not be
clearly chosen due to intraconal glioma, these parameters
of the eyes were not included in the statistical analyses of
the study.
Optic nerve tortuosity was assessed by the
neuroradiologist (M.B.) and graded as follows:
Grade 0: No tortuosity
Grade 1: Mild tortuosity
Grade 2: Moderate tortuosity
Grade 3: Severe tortuosity
The optic pathways including optic radiations were
also evaluated for the presence of any NBO, hamartoma,
myelin defect, axonal defect, or OPG. Gliomas of the optic
pathways were defined based on hyperintense appearance
(on FLAIR or T2W images) and thickening of optic pathway
structures [8]. The location (prechiasmatic, chiasmatic,
postchiasmatic) and the laterality (right-sided, left-sided,
bilateral) of the glioma in patients with OPG were classified.
Findings of STIR and 3D-SPACE sequences were compared
between groups and according to clinical findings.
2.1. Statistical analysis
Continuous variables were reported with median and
minimum–maximum values, and categorical variables were
presented as frequency and percentage. Kruskal–Wallis
and Mann–Whitney U tests were performed for group
comparisons. Categorical variables were compared between
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Table 1. 3-Tesla MRI protocol used for the study.
Sequences/ Parameters

3D-MPRAGE

3D-SPACE
(with VFAM)

STIR

FLAIR

TR/TE (ms)

2130/3.45

3000/579

5100/81

6000/405

TI (ms)

1100

-

150

2100

Slice thickness (mm)

0.8

0.6

3

0.9

FOV* (mm)

230 × 230

240 × 240

230 × 230

230 × 230

Acquisition time (min)

5

5

4

9

NEX

1

2

2

1

Number of slices

240

240

16

192

Flip angle (°)

8

100

120

-

Imaging plane

Sagittal

Sagittal

Axial-coronal

Sagittal

Distance factor

-

-

10%

-

PAT factor

2

2

-

--

PAT mode

GRAPPA

GRAPPA

-

-

Voxel size (mm)

0.8 × 0.8 × 0.8

0.6× 0.6 × 0.6

0.6 × 0.5 × 3

0.9 × 0.9× 0.9

FA mode

-

T2 variant

-

-

TI: Time of inversion; 3D-SPACE: three-dimensional sampling perfection with application-optimized
contrasts using different flip angle evolutions; 3D-MPRAGE: 3D T1W magnetization prepared rapid
acquisition gradient-echo; STIR: short tau inversion recovery; FLAIR: fluid-attenuated inversion recovery;
NEX: number of excitations; FOV: field of view; PAT: parallel acquisition technique; GRAPPA: generalized
autocalibrating partially parallel acquisitions. The advantage of 3D acquisition is the capability to reconstruct
the images at any angle and align with other acquisitions. Thus, multiplanar images were obtained from
3D-MPRAGE, SPACE, and FLAIR acquisitions.

Figure 1. Optic nerve (ON) and optic nerve sheath (ONS) measurements (arrows) of 3 patients with NF-1 on STIR (left and middle)
and 3D-SPACE (right) images.

groups using Pearson’s chi-square test, Fisher’s exact test,
and the Fisher–Freeman–Halton test. For determining
the reliability of 3D-SPACE and STIR measurements, the
intraclass correlation coefficient (ICC) was used. Statistical
signiﬁcance was set at P < 0.05.

1628

3. Results
Group 1 consisted of 20 patients. There were 10 males and
10 females with a mean age of 17.8 (7–41) years. Group
2 comprised 16 patients including 7 (43.8%) males and 9
(56.2%) females. Their mean age was 12 (6–21) years. The
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OPGs were right-sided in 4 (25%), left-sided in 2 (12.5%),
and bilateral in 10 (62.5%) patients in Group 2. The control
group consisted of 19 subjects, 9 (47.4%) males and 10
(52.6%) females, with a mean age of 18.3 (5–34) years.
The mean ONS diameters on STIR images were
significantly higher in Group 2 compared to Group 1 and
controls (p=0.009) (Table 2). The mean ONS diameter was
significantly higher in Group 2 when compared to Group
1 and the control group with the 3D-SPACE sequence
(p=0.017, Table 2). It was 4.4 mm (3.3–6.3), 5.4 mm (3.2–
14.5), and 5.1 mm (4.2–6.5) in Group 1, Group 2, and the
control group, respectively (p=0.019 for Groups 1 and 2,
p=0.007 for Group 1 and control group, p=0.607 for Group
2 and control group) (Table 2).
Measurements of ONS diameter obtained from STIR
and 3D-SPACE sequences were significantly correlated
with each other (p<0.001, ICC: 0.88, Table 3). Comparing
the distribution of the ON tortuosity grades across the
controls and Groups 1 and 2 (Table 4), control subjects
had significantly lower grades than both patient groups
(p=0.001). Group 1 also had significantly lower tortuosity
grades when compared to Group 2 (p=0.001). Severe
(grade 3) tortuosity was only detected in Group 2.
In Group 1 and Group 2, 7 (35%) and 5 (31.2%) patients
had a positive family history of NF-1, respectively. Seven
(35%) patients in Group 1 and 3 (18.7%) patients in Group

2 had Lisch nodules. There was no association between
the presence of any OPG and having a positive family
history, presence of any Lisch nodule, or hydrocephalus
(P > 0.05). Patients with headaches had higher (but not
statistically significant) ON thickness and ONS diameter
when compared to patients without headaches (Table 5).
Partial or complete type aqueduct stenosis was detected
in six of NF-1 patients, of whom three had hydrocephalus
(two patients in Group 1 and one patient in Group 2) and
the other three had functioning ventriculoperitoneal shunt
systems (Figure 2). Cranial MRI findings (except NBOs or
gliomas) of all NF-1 patients are given in Table 6. In total,
109 NBOs were detected in Group 1 and 97 were detected
in Group 2 with the STIR sequence imaging. 3D-SPACE
imaging demonstrated an additional 26 NBOs in Group 1
and 17 NBOs in Group 2 patients.
4. Discussion
This paper focuses on two main topics: the description of
the optic nerve in patients with NF-1, and the comparison
of NF-1-related findings on routinely performed MRI
sequences (2D-STIR) versus upcoming high-resolution
3D-MRI acquisition (3D-SPACE). Patients with OPGs are
at risk for vision loss. Optic pathway gliomas are one of the
seven diagnostic criteria of NF-1 [1–8]. Ophthalmologic
examination may show optic nerve dysfunction. Dilatation

Table 2. The median thickness of the optic nerve (ON) and the diameter of the optic nerve sheath (ONS)
measured with two different MRI sequences in groups.
MRI Sequence

Group 1
Median (min–max)

Group 2
Median (min–max)

Controls
Median (min–max)

p

ONS-SPACE (mm)

4.4 (3.3–6.3)

5.4 (3.2–14.5)

5.1 (4.2–6.5)

0.017

ON-SPACE (mm)

2.3 (1.5–3.5)

2.5 (1.4–34)

2.4 (1.7–3.7)

0.193

ONS-STIR (mm)

5.3 (4.3–7.3)

6.7 (4.4–14)

5.7 (5–7.3)

0.009

ON-STIR (mm)

3.2 (2.3–4.4)

3 (1.7–10)

2.8 (2.1–3.8)

0.804

Group 1: NF-1 patients without optic pathway glioma (OPG); Group 2: NF-1 patients with OPG.
Table 3. Compatibility and correlation analyses of the two methods (3D-SPACE and
STIR) for thickness of the optic nerve (ON) and diameter of the optic nerve sheath
(ONS).
Group 1

Group 2

Controls

Overall

ICC

P

ICC

P

ICC

P

ICC

p

ON

-

0.396

-

0.196

-

0.946

-

0.082

ONS

0.94

<0.001

0.95

<0.001

-

0.806

0.88

<0.001

ICC: Intraclass correlation coefficient, Group 1: NF-1 patients without optic pathway
glioma (OPG), Group 2: NF-1 patients with OPG.
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Table 4. The grades of optic nerve tortuosity in groups.
Grade

Group 1
# (%)

Group 2
# (%)

Controls
# (%)

Total
# (%)

0

6 (30)

2 (7.7)

17 (89.5)

25 (38.5)

1

9 (45)

9 (34.6)

2 (10.5)

20 (30.8)

2

5 (25)

4 (15.4)

0 (0)

9 (13.8)

3

0 (0)

11 (42.3)

0 (0)

11 (16.9)

Group 1: NF-1 patients without optic pathway glioma (OPG);
Group 2: NF-1 patients with OPG.

of the ONS and tortuosity of ON are other common MRI
findings in NF-1 patients [12–14]. ONS dilatation is the
nonprogressive enlargement of the subarachnoid space
surrounding the optic nerve, synonymous with dural
ectasia of the ONS [15]. ONS dilatation is a sign, not a
disease, and can easily be detected and measured with
MRI and CT scans. It is caused by underlying processes,
which themselves may need treatment, but ONS dilatation
itself does not need treatment.
Recent research indicates that ONS dilatation could be
a good indicator of increased intracranial pressure (ICP) in
NF-1 patients [14]. Therefore, ONS fenestration, a surgical
procedure to reduce the pressure within the subarachnoid
space of the optic nerve, could be helpful in the treatment
of severe ONS dilatation associated with progressive
visual loss due to papilledema [14–16]. Optic nerve sheath
dilatation can occur for other reasons unrelated to high
ICP and these cases are unlikely to benefit from ONS
fenestration.
Increased ON tortuosity has been demonstrated in the
optic pathway of NF-1 patients in a few reports [8,12–14].
In a recent study, the incidence of ON tortuosity was
reported as 84% in NF-1 patients [17]. The two most
reliable features of ON tortuosity were lack of congruity
in greater than one coronal section and dilatation of the
subarachnoid space surrounding the anterior portion of

the ON. Levin et al.’s study revealed that ON tortuosity
on baseline MRI was a predictor of subsequent OPG in
NF-1 patients, but not a predictor of clinically significant
OPG requiring treatment or resulting in poor vision. ON
thickness and ONS dilatation were not associated with
later appearance of OPG [8].
In the present study, we evaluated the optic pathways
of NF-1 patients with a 3T-MRI unit. We assessed and
compared the thickness and the tortuosity of the ON and
the diameter of the ONS in patients with or without OPG by
3D-SPACE and STIR sequences. Our study demonstrated
that the diameter of the ONS was significantly higher in
NF-1 patients regardless of the presence of OPG. The ON
thickness did not show any significant difference between
NF-1 patients and healthy subjects. We think that this
result is related to our measurement location because we
measured the ON diameter apart from the visible OPG in
NF-1 patients with OPG. The aim of this was to evaluate
the normal-appearing parts of the ONs.
The relationship between raised intracranial pressure
and the dilatation of the ONS has been known for several
years [15–18]. Also, it is known that NF-1 is associated
with altered or worsened CSF circulation due to fibrotic
changes of the arachnoid membranes [19]. Mild or
moderate intracranial hypertension might be present in
NF-1 patients regardless of having OPG. Supporting this
hypothesis, we observed that headache was more common
in NF-1 patients with more dilatated ONS. According to
our data, ONS diameter will not relate solely or principally
to the presence or absence of an OPG. In many cases, the
ONS dilatates secondary to the intracranial phenomena.
We think that studies monitoring the pressure of
cerebrospinal fluid are needed to support our findings.
ON tortuosity was assessed subjectively in our study.
Our findings revealed that the average ON tortuosity
for NF-1 patients with OPG was higher than that of the
NF-1 patients without OPG. NF-1 patients without OPG
also had more tortuous ONs when compared to healthy
subjects. Grade 3 ON tortuosity was only detected in NF-1
patients with OPG, while healthy subjects had none. We

Table 5. Relationship between the thickness of the optic nerve (ON) and optic nerve
sheath (ONS) diameter with the presence of headache in the whole NF-1 patient cohort.

Sequence
STIR
3D-SPACE

1630

No Headache

Headache

Median (min–max)

Median (min–max)

ON

2.90 (1.70–4.20)

3.35 (2.50–5.30)

0.182

ONS

5.70 (4.30–8.40)

6.10 (4.80–8.50)

0.457

ON

2.40 (1.50–34)

2.40 (1.80–4.90)

0.585

ONS

5 (3.20–6.50)

5.10 (3.50–8)

0.499

ON/ONS

P-value
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Figure 2. 3D-SPACE (T2W with variant FA mode) (A, B) and contrast-material enhanced MPRAGE (C–F) images of an NF-1
patient with optic pathway glioma (arrows) and aqueduct stenosis due to tectal glioma (dashed arrow).

think that increased ON tortuosity in NF-1 patients may
also indicate raised intracranial pressure and support our
previous findings.
Additionally, our results indicated that both
3D-SPACE and STIR sequences provide valuable imaging
information on the diameter of the ONS. Thin-section
conventional sequences would be preferable in evaluating
the morphology of the ON or other cranium structures
of the NF-1 patients [9]. Isotropic 3D-SPACE (<1 mm3)
data are useful for evaluation of these details and have
complementary capability for multiplanar high-resolution
CSF and whole cranium evaluation, but this needs more
experience. Importantly, 3D-SPACE and conventional
sequences for assessment of optic pathway structures seem
to complement each other and give partially different
information. 3D-SPACE imaging provides information
to be of potential use in daily clinical practice in easy
screening of the optic pathway and the whole cranium
with high resolution and low SAR levels [11].
The relationship between CSF-related disorders
(especially hydrocephalus) and NF-1 has already been
reported [9–19]. In our study, the 3D-SPACE sequence was
adequate for imaging of our patients with hydrocephalus
or ventriculoperitoneal shunt and their other intracranial

findings. In the literature, the 3D-SPACE technique
was reported as the easiest, fastest, and most adequate
sequence to determine the ventricular system and CSFrelated pathologies [20,21].
There are many T2W 3D-SPACE or 3D-TSE
sequences for evaluation of the cranium or brain [20].
The 3D-SPACE sequence of this study is not a heavily T2weighted sequence. It is a 3D-turbo spin echo (3D-TSE)
sequence with variant FA values [21]. According to our
observations, the increased signal intensity of some
lesions (e.g., an important feature of optic nerve gliomas)
may not be evaluated perfectly on 3D-SPACE images.
From a radiologist’s perspective, in the absence of other
findings, the tortuosity of the ON may cause confusion
among clinicians about the presence of optic nerve
glioma in the patient. The point is that the ON tortuosity
is not a unique indicator of the presence of optic pathway
gliomas.
According to the literature, the upper limit or
threshold value for ONS diameter is 6 mm in healthy
children and adolescents [22]. Our findings are consistent
with these statements. Median ONS values of our control
group for 3D-SPACE and STIR sequences are 5.1 and 5.7
mm, respectively.
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Table 6. Cranial MRI findings (except unidentified bright objects) of NF-1 patients in Groups 1 and 2.
Group 1

Number of patients

Number of pathologies

Hyperintense bone lesion on T2W images

1

1

Mucosal thickening of the paranasal sinuses

5

13

Cavum septum pellucidum

1

1

Abnormal course of the optic nerve

1

1

Adenoid vegetation

4

4 (bilaterally)

Pineal cyst

1

1

Encephalomalacia due to trauma or surgery

1

1

Intracranial cystic lesion (e.g., arachnoid cyst)

2

3

Intracranial hypotension

1

1

Group 2

Number of patients

Number of pathologies

Nonoptic pathway glioma

4

5

Mucosal thickening of the paranasal sinuses

7

16

Adenoid vegetation

4

4 (bilaterally)

Encephalomalacia due to trauma or surgery

1

1

Contrast-material enhanced glioma

4

4

Hyperintense bone lesion on T2W images

1

2

Hypophyseal adenoma

1

1

Mega cisterna magna

1

1

Group 1: NF-1 patients without optic pathway glioma (OPG), Group 2: NF-1 patients with OPG

In contrast with the ONS diameter, ON measurements
were not correlated between the 3D-SPACE and STIR
sequences (Table 3). These results are probably due to the
fact that 3D-SPACE with variant or variable FA technique is
more sensitive to the delineation of intraconal ON than the
STIR images. On these types of 3D-SPACE images, intraconal
ON visibility is lesser than in STIR images because STIR is
a fluid-sensitive, fat-saturated, and relatively heavily T2W
technique. 3D-SPACE or 3D-TSE images with constant FA
values may be more useful for delineation of ON/ONS and
comparison of these values with STIR sequence.
There are some limitations to our study. First, monitoring
with MRI and clinical exams frequently decreases
dramatically after age 8. Furthermore, OPGs are known
to regress into adulthood. Since sedation was needed, we
could not include more pediatric cases in the study groups.
Second, the proof or exclusion of an OPG was subjectively
determined due to ethical reasons. Enlargement of the optic
nerve in the setting of NF-1 is assumed to be a sign of OPG
and biopsy confirmation is generally not required. Contrastmaterial enhancement on T1W images suggests more active
disease, but OPG is suspected even in nonenhancing slight
expansion of the optic nerve. However, the exact diagnosis
of the OPG is made by biopsy. Third, the cross-section of the
optic nerve is around 3 mm in all three groups. The voxel

1632

sizes of 3D-SPACE and 2D-STIR sequences are 0.6 × 0.6 ×
0.6 and 0.6 × 0.5 × 3 mm, respectively. These values may
be inadequate for optic nerves, and subtle size differences
are within the margin of error (especially for STIR images).
Fourth, this is a small study in which STIR statistically
performed slightly better than 3D-SPACE imaging in
assessing ON thickness. Also, STIR can offer an advantage
in terms of assessment of the optic nerve signal. Finally,
interrater and intrarater variability assessments would
be helpful for optimal detection of possible differences
between sequences and other parameters.
In conclusion, our findings revealed that the ON
is more tortuous and ONS is more dilatated in NF-1
patients (especially in cases with OPG). Additionally, highresolution 3D cranium imaging with 3D-SPACE is useful
for the management of patients with NF-1. The 3D-SPACE
technique is safe, efficient, and relatively easy in assessing
the optic pathways in NF-1 patients. In the current study,
we apparently demonstrated the equivalency of T2W
3D-SPACE versus STIR for measurement of the ON and
ONS in the NF-1 population and controls. Further studies
with large patient groups are needed to support our findings.
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